Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 32, Issue 4, 2004, Pages 575-591

  Xue, Shen Wu ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Controlled release; Drug delivery; Microspheres; Poly(lactic co glycolic acid); Progesterone

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; ENCAPSULATION; ORGANIC ACIDS; ORGANIC POLYMERS; SYNTHESIS (CHEMICAL);

CONTROLLED RELEASE DEVICES; DRUG DELIVERY; LACTIC/GLYCOLIC ACID POLYMERS (PLGA); MICROSPHERES;

BIODEGRADATION;

MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID; PROGESTERONE; SOLVENT;

ARTICLE; BIODEGRADABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EXTRACTION; MICROENCAPSULATION; MICROSCOPY; MOLECULAR WEIGHT; NORMAL DISTRIBUTION; PARTICLE SIZE; SYNTHESIS;

BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; PROGESTERONE;

EID: 10644240952     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIO-200039635     Document Type: Article

References (27)

1. Agarwal, R. K., Robinson, D. H., Maze, G. I., Reinhardt, R. A. (1993). Development and characterization of tetracycline-poly(lactide/glycolide) films for the treatment of periodontitis. J. Controlled Rel. 23:137-147.
2. Arshady, R. (1991). Preparation of biodegradable microspheres and microcapsules: 2. Polylactides and related polyesters. J. Controlled Rel. 17:1-12.
3. Asano, M., Fukuzaki, H., Yoshida, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K., Yamanaka, H. (1990). Application of poly DL-lactic acids of varying molecular weight in drug delivery systems. Drug Design Deliv. 5:301-320.
4. Brady, J. M., Cutright, D. E., Miller, R. A., Battistone, G. C. (1973). Resorption rate, route of elimination and ultrastucture of the implant site of poly(lactic acid) in the abdominal wall of the rat. J. Biomed. Mater. Res. 7:155-166.
5. Dunn, R. L., Lewis, D. H., Beck, L. R. (1981). Fibrous polymers for the delivery of contraceptive steroids to the female reproductive tract. In: Lewis, D.H., ed. Controlled Release of Pesticides and Pharmaceuticals. New York: Plenum Publishing Corporation, pp. 125-164.
6. Dunn, R. L., Lewis, D. H., Goodson, J. M. (1982). Monolithic fibers for controlled delivery of tetracycline. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 9:157-159.
7. Dunn, R. L., English, J. P., Strobel, J. D., Cowsar, D. R., Tice, T. R. (1988). Preparation and evaluation of lactic/glycolic acid copolymers for drug delivery. In: Migliaresi, C., et al., ed. Polymers in Medicine. Vol. 3. Amsterdam, The Netherlands: Elsevier Science Publishers, pp. 149-160.
8. Fong, J. W. (1988). Microencapsulation by solvent evaporation and organic phase separation processes. In: Hsieh, D., ed. Controlled Release Systems: Fabrication Technology. Vol. 1. Boca Raton, FL: CRC Press, Inc., pp. 81-108.
9. Fukuzaki, H., Yoshida, M., Asano, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K., Yamanaka, H. (1991). In vivo characteristics of high molecular weight copoly(L-lactide/glycolide) with S-type degradation pattern for application in drug delivery systems. Biomaterials 12:433-437.
10. Gardner, D. L., Fink, D. J. (1980). Biodegradable microcapsules and microparticles for contraceptions. In: Hafez, E. S. E., van Os, W. A. A., eds. Progress in Contraceptive Delivery Systems. Biodegradables and Delivery Systems for Contraception. Vol. 1. Lancaster, England: MTP Press Ltd., pp. 47-62.
11. Hockaday, T. D. R., Frederick, E. W., Clayton, J. E., Smith, L. H. Jr. (1965). Studies on primary hyperoxaluria. II. Urinary oxalate, glycolate, and glyoxylate measurement by isotope dilution methods. J. Lab. Clin. Med. 65:677-687.
12. Ike, O., Shimizu, Y., Wada, R., Hyon, S. H., Ikada, Y. (1992). Controlled cisplatin delivery system using poly(D,L-lactic acid). Biomaterials 13:230-234.
13. Jalil, R., Nixon, J. R. (1990a). Biodegradabale poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsulation 7:297-325.
14. Jalil, R., Nixon, J. R. (1990b). Microencapsulation using poly(L-lactic acid). IV. Release properties of microcapsule containing phenobarbitone. J. Microencapsulation 7:53-66.
15. Julienne, M. C., Alonso, M. J., Gomez Amoza, J. L., Benoit, J. P. (1992). Preparation of poly(D,L-lactide/glycolide) nanoparticles of controlled particle size distribution: application of experimental designs. Drug Develop. Industr. Pharm. 18:1063-1077.
16. Lewis, D. H. (1990). Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasin, M., Langer, R., eds. Biodegradable Polymers as Drug Delivery Systems. New York: Marcel Dekker, Inc., pp. 1-41.
17. Marcotte, N., Goosen, M. F. A. (1989). Delayed release of water-soluble macromolecules from polylactide pellets. J. Controlled Release 9:75-85.
18. Omelczuk, M., McGinity, J. W. (1993). The influence of thermal treatment on the physical-mechanical and dissolution properties of tablets containing poly(D,L-lactic acid). Pharm Res. 10:542-548.
19. Pitt, C. G., Gratzl, M. M., Jeffcoat, A. R., Zweidinger, R., Schindler, A. (1979). Sustained drug delivery systems. II. Factors affecting release rates from poly(ε-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. 68:1534-1538.
20. Sampath, S. S., Garvin, K., Robinson, D. H. (1992). Preparation and characterization of biodegradable poly(L-lactic acid) gentamicin delivery systems. Intern. J. Pharm. 78:165-174.
21. Spilizewski, K. L., Marchant, R. E., Hamlin, C. R., Anderson, J. M., Tice, T. R., Dappert, T. O., Meyer, W. E. (1987). The effect of hydrocortisone acetate loaded poly(D,L-lactide) films on the inflammatory response. In: Anderson, J. M., Kim, S. W., eds. Advances in Drug Delivery Systems. Vol. 3. Amsterdam, The Netherlands: Elsevier Scientific Publishing, pp. 197-203.
22. Thies, C., Bissery, M. C. (1984). Biodegradable microspheres for parenteral administration. In: Lim, F., ed. Biomedical Applications of Microencapsulation. Boca Raton, FL: CRC Press, Inc., pp. 53-74.
23. Wang, H. T., Schmitt, E., Flanagan, D. R., Linhardt, R. J. (1991). Influence of formulation methods on the in vitro controlled release of protein from poly(ester) microspheres. J. Controlled Rel. 17:23-32.
24. Wang, N., Wu, X. S., Li, C., Feng, M. F. (2000). Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part I. Synthesis and characterization. J. Biomater. Sci.: Polym. Ed. 11(3):301-318.
25. Wu, X. S. (1995a). Synthesis and properties of biodegradable lactic/glycolic acid polymers. In: Wise, D. L., Trantolo, D. J., Altobelli, D. E., Yaszemski, M. J., Gresser, J. D., Schwartz, E. R., eds. Encyclopedic Handbook of Biomaterials and Bioengineering, Part A: Materials. Vol. 2. New York: Marcel Dekker, Inc., pp. 1015-1054.
26. Wu, X. S. (1995b). Preparation, characterization, and drug delivery applications of microspheres based on biodegradable lactic/glycolic acid polymers. In: Wise, D. L., Trantolo, D. J., Altobelli, D. E., Yaszemski, M. J., Gresser, J. D., Schwartz, E. R., eds. Encyclopedic Handbook of Biomaterials and Bioengineering, Part A: Materials. New York: Marcel Dekker, Inc., pp. 1151-1200.
27. Wu, X. S. (2001). Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II. Biodegradation. J. Biomater. Sci.: Polym. Ed. 12(1):21-34.